argenx SE

Below you will find information from the register publication of inside information. The information has been provided by the organisation.

  • Registration date 08 oct 2021 - 07:00
  • Statutory name argenx SE
  • Title argenx to Highlight Potential First-in-Class FcRn Antagonist Efgartigimod at Upcoming Neuromuscular Meetings

Related downloads

202110080000000001_argenx Press Release-AANEM 2021 Curtain Raiser FINAL.pdf

Date last update: 22 January 2022

Share information

Share on: Share this